Ranitidine
150 mg № 20
Pharmacotherapeutic group
Active ingredient
Pharmaceutical form
Film-coated tablets
ATC code
A02BA02
RX/OTC
RX
Registration certificate
UA/4821/01/01
General properties
Pharmacotherapeutic group
Agents for treatment of peptic ulcer and gastroesophageal reflux disease. H2 receptor antagonists. Ranitidine.
Therapeutic indications
- Peptic ulcer and duodenal ulcers, not associated with Helicobacter pylori (in exacerbation phase), including ulcers associated with nonsteroidal anti-inflammatory drugs (NSAIDs);
- functional dyspepsia;
- chronic gastritis with increased acid-forming function of the stomach in exacerbation phase;
- gastroesophageal reflux disease (to relieve symptoms) abo reflux esophagitis.
Contraindications
Individual hypersensitivity to the drug; the presence of malignant diseases of the stomach, liver cirrhosis with portosystemic encephalopathy in anamnesis; severe renal insufficiency.
Pharmaceutical characteristics
Main physicochemical properties
Film-coated tablets from light orange to orange in color, with a biconvex surface. At the break is seen under a magnifying glass core surrounded by a continuous layer.
Shelf life
3 years.
Storage
Store in original packaging at a temperature not exceeding 25 °C.
Keep out of the reach of children.
Manufacturer
PJSC "Technolog".
Location
8, Stara Prorizna st., Uman 20300 Cherkasy region, Ukraine.
